← Back to Search

4D Imaging Techniques for Lung Cancer

N/A

Recruiting

Led By Daniel Saenz, PhD

Research Sponsored by The University of Texas Health Science Center at San Antonio

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with cancer or presumed cancer involving the lung (primary or secondary) planned to undergo lung SBRT technique or IMRT technique with an SBRT setup in 10 or fewer fractions

Age ≥ 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 weeks

Awards & highlights

Study Summary

This trial will compare two ways of taking CT scans to account for the fact that a patient's lungs move while receiving radiation therapy.

Who is the study for?

This trial is for adults over 18 with lung cancer (primary or secondary) who are set to undergo a specific type of radiation therapy in 10 or fewer sessions. They must be able to consent and understand English or Spanish. It's not suitable for those with poor lung function, multiple treatment targets at once, pregnant individuals, or anyone whose condition could affect therapy adherence.Check my eligibility

What is being tested?

The study compares two CT imaging techniques during radiation therapy for lung tumors: traditional free-breathing CT versus a more comprehensive CT that captures the entire breathing cycle. The goal is to see which method best aligns with patients' actual breathing during treatment.See study design

What are the potential side effects?

Since this trial focuses on imaging techniques rather than medication, typical drug side effects aren't expected. However, there may be discomfort from staying still during longer scans and potential risks associated with increased exposure to radiation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for a specific lung cancer radiation treatment in 10 or fewer sessions.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To investigate radiation therapy treatment tumor localization accuracy by determining whether the FB or AIP images is more representative of the target at treatment.

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: AIP (Average Intensity Projection) CT (Computed Tomagraphy)Active Control1 Intervention

An image taken over a longer time of the lungs (average intensity projection of 4DCT) will be compared with breathing during treatment.

Group II: FB (Free-Breathing) CTPlacebo Group1 Intervention

A snapshot of breathing (free-breathing traditional CT) will be used to compare with breathing during treatment.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor

452 Previous Clinical Trials

91,365 Total Patients Enrolled

Daniel Saenz, PhDPrincipal InvestigatorUT Health San Antonio

Media Library

AIP (Average Intensity Projection) CT (Computed Tomagraphy) Clinical Trial Eligibility Overview. Trial Name: NCT04717804 — N/A

Lung Cancer Research Study Groups: FB (Free-Breathing) CT, AIP (Average Intensity Projection) CT (Computed Tomagraphy)

Lung Cancer Clinical Trial 2023: AIP (Average Intensity Projection) CT (Computed Tomagraphy) Highlights & Side Effects. Trial Name: NCT04717804 — N/A

AIP (Average Intensity Projection) CT (Computed Tomagraphy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04717804 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been included in this clinical experiment thus far?

"Affirmative. The evidence on clinicaltrials.gov verifies that this trial, which was initiated on August 17th 2021, is currently recruiting patients. 45 participants are sought from one research centre."

Answered by AI

Are there still vacancies for participation in this experiment?

"Clinicaltrials.gov indicates that the recruitment process for this medical trial is ongoing, with a commencement date of August 17th 2021 and an edit to the post on September 12th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients

Daniel Saenz 2021. "4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04717804.

All > Lung Cancer Austin